Inaccurate and Incomplete PASRR Screenings for Residents With Mental Health Diagnoses
Summary
The deficiency involves the facility’s failure to ensure that Level I PASRR screenings were accurately completed and updated for two residents with documented mental health diagnoses and psychotropic medication use. For one resident with Parkinson’s disease, schizoaffective disorder, and anxiety disorder, the Level I PASRR dated May 6, 2024 indicated that a Level II PASRR referral was not necessary. However, the section of the Level I PASRR that asked whether the resident had a diagnosis of schizoaffective disorder was not checked, despite the resident’s documented diagnosis and use of psychotropic medications including bupropion, trazodone, and Depakote. The resident’s care plan was later revised to include a focus on psychosocial well-being related to schizophrenia, and a quarterly MDS showed intact cognition with a BIMS score of 15. During an interview, the Social Services Director confirmed that this resident had a PASRR I in the record and acknowledged that the schizophrenia diagnosis was not listed on the form. He stated he was unsure why the diagnosis was not included and indicated that he would have expected the schizophrenia diagnosis to be identified on the PASRR I if the resident had that diagnosis. This reflects that the documented mental health condition and related psychotropic medication use were not accurately captured on the PASRR screening, despite being present in the clinical record and care plan. For the second resident, who had diagnoses including anxiety disorder, bipolar disorder (including a current manic episode with psychotic features), depression, and generalized anxiety disorder, the Level I PASRR dated December 14, 2023 showed no evidence of mental illness, no symptoms, no history of psychiatric treatment, and no psychotropic medications. This conflicted with the admission MDS, which documented severe cognitive impairment (BIMS score of 5), multiple depressive symptoms over the prior 14 days with a severity score of 12 indicating moderate depression, social isolation, and diagnoses of anxiety disorder, depression, and bipolar disorder. The MDS also documented that the resident had been taking antianxiety medications, and the care plan included focuses on risk for adverse reactions to psychotropic medications, mood problems related to depression, bipolar disorder, and anxiety, and the use of behavioral health consults as needed. The resident’s record further showed multiple psychotropic medication orders over time, including buspirone, trazodone, lorazepam, suvorexant, doxepin, and bupropion, with indications such as anxiety, depression, insomnia, agitation, restlessness, hallucinations, and anhedonia. Care plan focuses documented use of psychotropic, antianxiety, and antidepressant medications related to bipolar disorder, anxiety disorder, and depression, as well as limited activity involvement related to anxiety and depression. Despite this, the PASRR form for this resident contained no evidence of diagnoses or medications. In interviews, the Social Services Director stated he had never been formally trained on the PASRR process, was not familiar with what a completed PASRR form should look like, and had difficulty using the website he believed was for PASRR submissions. He acknowledged that the resident’s diagnoses and medications would have been triggers for a Level II PASRR submission and was unsure how to address inaccurate PASRR information. The DON stated that the PASRR process involved receiving a form from the hospital to ensure appropriate placement and treatment, and that if a resident stayed beyond 30 days and had an appropriate diagnosis, a Level II form should be sent to the state agency. She reported there was no in-house PASRR training and that additional training could be requested for the Social Services Director. She also stated she had only learned that a corporate contact in another state handled the facility’s PASRR process and was unsure if that person knew Arizona regulations. Regarding the second resident, the DON stated that the diagnoses of anxiety, depression, bipolar disorder, and bipolar disorder with psychotic features would have been appropriate for a Level II PASRR submission and identified inaccurate completion of PASRR sections requiring information on exemptions, mental illness diagnoses, symptoms, psychiatric history, and medications. She confirmed there was no evidence of a Level II PASRR for this resident and stated that not submitting a Level II form for a resident who could benefit from state agency review could leave the resident at a disadvantage in receiving appropriate review of behavioral health interventions. The facility’s PASRR policy required validation that each resident is screened for mental disorder or intellectual disability before admission, referral of residents with newly evident or possible mental disorder or intellectual disability to the state authority, and incorporation of Level II determinations and recommendations into assessments and care plans, which was not followed in these cases.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



